CyclinD1 is a new target gene of tumor suppressor miR-520e in breast cancer

• Published in: Open medicine (Warsaw, Poland) Poland), 2019-01, Vol.14 (1), p.913-919
• Main Authors: Liang, Quan, Yao, Qingjuan, Hu, GuoYing
• Format: Article
• Language: English
• Subjects: Binding sites; Bioinformatics; Breast cancer; CyclinD1; miR-520e
• ISSN: 2391-5463; 2391-5463
• DOI: 10.1515/med-2019-0108

To investigate the involvement of miR-520e in the modulation of cancer-promoting cyclinD1 in breast cancer. A reverse transcription-polymerase chain reaction (RT-PCR) was applied to test the regulation of miR-520e on cyclinD1. The binding of miR-520e to 3'-untranslated region (3'UTR) of cyclinD1 mRNA was predicted by an online bioinformatics website. The effect of miR-520e on the luciferase reporters with binding sites of miR-520e and 3'UTR of cyclinD1 mRNA was revealed using a luciferase reporter gene assay. The correlation between miR-520e and cyclinD1 in clinical breast cancer samples was detected through quantitative real-time PCR. The expression of cyclinD1 was gradually reduced as the dose of miR-520e increased. Anti-miR-520e obviously induced cyclinD1 in breast cancer cells. After anti-miR-520e was introduced into the cells, the inhibition of cyclinD1 expression mediated by miR-520e was reversed. The binding of miR-520e with cyclinD1 was revealed via bioinformatics. Under the treatment of dose-increasing miR-520e or anti-miR-520e, the luciferase activities of cyclinD1 3'UTR vector were lower or higher by degrees. However, the activity of the mutant vector was not affected at all. Finally, in clinical breast cancer tissues the negative correlation of miR-520e with cyclinD1 was revealed. In conclusion, cyclinD1 is a new target of miR-520e in breast cancer.